RMG Wealth Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Buy
+70
New ﹤0.01% 664
2025
Q4
Sell
-70
Closed 516
2025
Q3
$0 Hold
70
﹤0.01% 360
2025
Q2
$0 Buy
+70
New ﹤0.01% 326

RMG Wealth Management's KLDO Position: Q1 2026 in Review

RMG Wealth Management opened a new position in Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2026: 70 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #664 among its holdings. This is a return to the name: RMG Wealth Management previously reported a position in KLDO as recently as Q3 2025.

RMG Wealth Management first reported a position in KLDO in Q2 2025 and has held it in 3 quarters since. 3 funds tracked by Wall St. Rank hold KLDO as of Q1 2026.

  • RMG Wealth Management held 70 shares of Kaleido Biosciences, Inc. Common Stock worth $0 as of Q1 2026.
  • Kaleido Biosciences, Inc. Common Stock was a new RMG Wealth Management position in Q1 2026.
  • Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of RMG Wealth Management's portfolio in Q1 2026, its #664 holding.
  • RMG Wealth Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2025 and has held it in 3 quarters since.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.